SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS AND THE POTENTIAL FOR DIABETIC KETOACIDOSIS

被引：0
|
作者：
Melnick, Stephen [1 ]
Basnet, Sijan [2 ]
Sharma, Priyadarshani [3 ]
Nazir, Salik [4 ]
机构：
[1] Reading Hlth Syst, Lebanon, PA USA
[2] Reading Hosp, W Reading, PA USA
[3] Reading Hosp, Reading, PA USA
[4] Reading Hlth Syst, W Reading, PA USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S617 / S618
页数：2
相关论文
共 50 条
  • [31] Sodium glucose co-transporter 2 inhibitors in heart failure therapy
    Cavusoglu, Yuksel
    Altay, Hakan
    Cahn, Avivit
    Celik, Ahmet
    Demir, Serafettin
    Kilicaslan, Baris
    Nalbantgil, Sanem
    Raz, Itamar
    Temizhan, Ahmet
    Yildirimturk, Ozlem
    Yilmaz, Mehmet Birhan
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2020, 48 (03): : 330 - 354
  • [32] A REVIEW ON SODIUM GLUCOSE CO-TRANSPORTER(SGLT-2) INHIBITORS
    Ramya, S.
    Susmitha, G.
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 109 - 112
  • [33] Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors
    Lahnwong, Sarayut
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [34] TEMPORAL CHANGE IN THE USE OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS
    Offiah, G.
    O'Connor, C.
    Khan, B.
    Moore, D.
    HEART, 2020, 106 : A17 - A18
  • [35] Harms and benefits of sodium-glucose co-transporter 2 inhibitors
    Chesterman, Thomas
    Thynne, Tilenka R. J.
    AUSTRALIAN PRESCRIBER, 2020, 43 (05) : 168 - 171
  • [36] Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
    Van Raalte, Daniel H.
    Heerspink, Hiddo Lambers
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications
    Kasbawala, Kinjal
    Stamatiades, George A.
    Majumdar, Sachin K.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 4
  • [38] Repurposing antidiabetic medications for gout: the potential of sodium glucose co-transporter 2 inhibitors Comment
    Neogi, Tuhina
    LANCET RHEUMATOLOGY, 2019, 1 (04): : E197 - E199
  • [39] Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature
    Bonora, Benedetta Maria
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES OBESITY & METABOLISM, 2018, 20 (01): : 25 - 33
  • [40] Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes
    Boyle, Luke D.
    Wilding, John P. H.
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (03) : 375 - 391
12345